Enfusion, Inc. (ENFN)
NYSE: ENFN · Real-Time Price · USD
10.10
+0.21 (2.12%)
Nov 21, 2024, 3:59 PM EST - Market closed
Enfusion Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 48.3 | 35.6 | 62.55 | 64.37 | 13.94 | 5.9 |
Cash & Short-Term Investments | 48.3 | 35.6 | 62.55 | 64.37 | 13.94 | 5.9 |
Cash Growth | 52.59% | -43.07% | -2.83% | 361.80% | 136.32% | - |
Receivables | 32.17 | 28.07 | 25.86 | 18.22 | 12.18 | 8.98 |
Prepaid Expenses | 3.58 | 5.01 | 6.11 | 6.03 | 2.79 | 1.29 |
Other Current Assets | 1.39 | 1.17 | 2.3 | 1.06 | - | - |
Total Current Assets | 85.44 | 69.85 | 96.81 | 89.68 | 28.91 | 16.17 |
Property, Plant & Equipment | 39.44 | 32.62 | 22.49 | 13.05 | 8.78 | 6.01 |
Long-Term Deferred Charges | - | 3.5 | 2.8 | - | - | - |
Other Long-Term Assets | 7.07 | 3 | 1.68 | 3.36 | 1.4 | 1.02 |
Total Assets | 134.94 | 108.97 | 123.78 | 106.09 | 39.1 | 23.2 |
Accounts Payable | 1.18 | 2.21 | 1.69 | 2.53 | 0.48 | 0.44 |
Accrued Expenses | 14.13 | 11.44 | 11.38 | 4.36 | 6.96 | 6.85 |
Current Portion of Long-Term Debt | - | - | - | - | 2.5 | 0.3 |
Current Portion of Leases | 5.94 | 4.26 | 4.03 | - | - | - |
Current Income Taxes Payable | 2.33 | 2.4 | 0.29 | 1.22 | 0.41 | 0.29 |
Other Current Liabilities | - | - | - | - | 0.3 | 0.19 |
Total Current Liabilities | 23.57 | 20.31 | 17.38 | 8.11 | 10.65 | 8.07 |
Long-Term Debt | - | - | - | - | 96.06 | 27.36 |
Long-Term Leases | 15.19 | 11.18 | 2.96 | - | - | - |
Other Long-Term Liabilities | - | - | - | 0.54 | 0.43 | 0.58 |
Total Liabilities | 38.76 | 31.49 | 20.34 | 8.64 | 107.14 | 36 |
Common Stock | 0.13 | 0.13 | 0.11 | 0.11 | -233.35 | -117.78 |
Additional Paid-In Capital | 240.22 | 226.88 | 244.26 | 226.72 | - | - |
Retained Earnings | -170.23 | -172.93 | -178.86 | -171.21 | - | - |
Comprehensive Income & Other | -0.2 | -0.41 | -0.5 | -0.33 | -0.21 | -0.1 |
Total Common Equity | 69.92 | 53.67 | 65.01 | 55.3 | -233.56 | -117.88 |
Minority Interest | 26.25 | 23.82 | 38.44 | 42.15 | - | - |
Shareholders' Equity | 96.18 | 77.48 | 103.44 | 97.44 | -68.04 | -12.81 |
Total Liabilities & Equity | 134.94 | 108.97 | 123.78 | 106.09 | 39.1 | 23.2 |
Total Debt | 21.13 | 15.44 | 6.99 | - | 98.56 | 27.66 |
Net Cash (Debt) | 27.17 | 20.17 | 55.56 | 64.37 | -84.63 | -21.76 |
Net Cash Growth | 79.24% | -63.70% | -13.69% | - | - | - |
Net Cash Per Share | 0.21 | 0.16 | 0.65 | 0.78 | -1764.20 | - |
Filing Date Shares Outstanding | 94.37 | 89.87 | 73.07 | 65.58 | 0.05 | - |
Total Common Shares Outstanding | 93.26 | 88.33 | 70.86 | 65.58 | 0.05 | - |
Working Capital | 61.87 | 49.54 | 79.43 | 81.57 | 18.26 | 8.1 |
Book Value Per Share | 0.75 | 0.61 | 0.92 | 0.84 | -4869.06 | - |
Tangible Book Value | 69.92 | 53.67 | 65.01 | 55.3 | -233.56 | -117.88 |
Tangible Book Value Per Share | 0.75 | 0.61 | 0.92 | 0.84 | -4869.06 | - |
Machinery | - | 17.52 | 17.93 | 14.7 | 9.2 | 5.72 |
Leasehold Improvements | - | 1.67 | 1.83 | 1.95 | 1.41 | 1.19 |
Source: S&P Capital IQ. Standard template. Financial Sources.